Gene · 9536
Papers2,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial mapping of the AA-PGE2-EP axis in multiple sclerosis lesions. | Acta Neuropathol | 2025 | 40299057 | PubTator, text mining | PubMed |
| Profiling the Anti-Photoaging Impact of Titanium Dioxide and Zinc Oxide Nanoparticles: A Focus on Signaling Pathways. | FASEB J | 2025 | 40293778 | PubTator, text mining | PubMed |
| Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer. | BMC Cancer | 2025 | 40269781 | PubTator, text mining | PubMed |
| Aspirin Eugenol Ester Alleviates Energy Metabolism Disorders by Reducing Oxidative Damage and Inflammation in the Livers of Broilers Under High-Stocking-Density Stress. | Int J Mol Sci | 2025 | 40076504 | PubTator, text mining | PubMed |
| Effects of Astragalus membranaceus Leaf Extract on Allergic Inflammation in Immune Cell Lines. | Prev Nutr Food Sci | 2025 | 40059916 | PubTator, text mining | PubMed |
| Furazanopyrazine-based novel promising anticancer agents interfering with the eicosanoid biosynthesis pathways by dual mPGES-1 and sEH inhibition. | Eur J Med Chem | 2025 | 40010271 | PubTator, text mining | PubMed |
| LIN28B enhances the chemosensitivity of colon cancer cells via inducing genomic instability by upsetting the balance between the production and removal of reactive oxygen species. | Cancer Lett | 2025 | 39986369 | PubTator, text mining | PubMed |
| Structure Bioinformatics of Six Human Integral Transmembrane Enzymes and their AlphaFold3 Predicted Water-Soluble QTY Analogs: Insights into FACE1 and STEA4 Binding Mechanisms. | Pharm Res | 2025 | 39966220 | PubTator, text mining | PubMed |
| Lipid mediators in post-mortem brain samples from patients with Alzheimer's disease: A systematic review. | Brain Behav Immun Health | 2025 | 39896840 | PubTator, text mining | PubMed |
| Discovery of novel microsomal prostaglandin E2 synthase 1 (mPGES-1) inhibitors by a structurally inspired virtual screening study. | J Mol Graph Model | 2025 | 39893902 | PubTator, text mining | PubMed |
| Galegine, a Bioprivileged Alkaloid from Tithonia tubaeformis: Antipyretic Activity Insights. | Curr Top Med Chem | 2025 | 39886793 | PubTator, text mining | PubMed |
| Participation of COX2/mPGES1/PGE2 in mouse and human endometrial stromal decidualization. | BMC Vet Res | 2025 | 39885565 | PubTator, text mining | PubMed |
| Extended protective effects of three dimensional cultured human mesenchymal stromal cells in a neuroinflammation model. | World J Stem Cells | 2025 | 39866897 | PubTator, text mining | PubMed |
| 2-Phenylbenzothiazoles featuring heteroaryl sulfonamide end-capping substructures as developable mPGES-1 inhibitors. | Arch Pharm (Weinheim) | 2025 | 39817627 | PubTator, text mining | PubMed |
| 5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidates. | Arch Pharm (Weinheim) | 2025 | 39692230 | PubTator, text mining | PubMed |
| Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium. | Reprod Sci | 2025 | 39174854 | PubTator, text mining | PubMed |
| Myeloid Cell mPGES-1 Deletion Attenuates Calcium Phosphate-induced Abdominal Aortic Aneurysm in Male Mice. | Inflammation | 2025 | 38865056 | PubTator, text mining | PubMed |
| Identifying inflammation-related targets of natural lactones using network pharmacology, molecular modeling and in vitro approaches. | J Biomol Struct Dyn | 2025 | 38334283 | PubTator, text mining | PubMed |
| A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's. | Rheumatology (Oxford) | 2025 | 38291895 | PubTator, text mining | PubMed |
| Heat-Killed Lactobacillus delbrueckii subsp. lactis 557 Extracts Protect Chondrocytes from Osteoarthritis Damage by Reducing Inflammation: An In Vitro Study. | Nutrients | 2024 | 39771038 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9536/papers?page=5